2010
DOI: 10.1111/j.1365-2184.2010.00668.x
|View full text |Cite
|
Sign up to set email alerts
|

Recombinant human midkine stimulates proliferation of articular chondrocytes

Abstract: Our results demonstrate that rhMK stimulates proliferation of primary articular chondrocytes in vitro and in vivo. The results of this study warrant further examination of rhMK for treatment of animal models of articular cartilage defects.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
13
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(13 citation statements)
references
References 42 publications
(61 reference statements)
0
13
0
Order By: Relevance
“…4a). One explanation for this might be that rhMK promotes the regeneration of the cartilage, 24,25) while the etiology, destabilized medial meniscus always exist during the process and make the neonatal chondrocytes and cartilage matrix disorganized.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…4a). One explanation for this might be that rhMK promotes the regeneration of the cartilage, 24,25) while the etiology, destabilized medial meniscus always exist during the process and make the neonatal chondrocytes and cartilage matrix disorganized.…”
Section: Resultsmentioning
confidence: 99%
“…24) In the DMM OA model, rhMK treatment also benefited the repair of the cartilage injury especially for the cellularity and cartilage staining but not for the structure and tidemark integrity, which might be because the etiology, DMM always exist in this DMM OA model, making the neonatal cartilage continuously in a turn-over state without ordered organization. What is exiting to us is that rhMK treatment attenuated the allodynia and therefore increased the physical activity behavior of the OA mice.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…13) In addition to receptor ALK, MK and PTN also activate extracellular signal-regulated kinase (ERK1/2) and PI3K/AKT pathways through receptor RPTPζ on osteoblast-like cells 88) and through both ανβ3 and RPTPζ on HUVEC. 54) In the presence of MK, the MAPK and PI3K/AKT pathways participate in injured tissues recovery process, like the recovery of ischemic myocardial injury, [23][24][25][26][27] cartilage trauma [89][90][91] and amphetamine-induced neurotoxicity. 92) MAPK and PI3K/AKT pathways also take part in the proliferation and self-renewal of stem cells, like embryonic stem cells (ES) 20) and hematopoietic stem cell (HSC) after stimulation by PTN.…”
Section: )mentioning
confidence: 99%